FibroGen Inc [NASDAQ: FGEN] price surged by 37.44 percent to reach at $0.21.
The one-year FGEN stock forecast points to a potential upside of 92.3. The average equity rating for FGEN stock is currently 2.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on FibroGen Inc [FGEN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for FGEN shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on FGEN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for FibroGen Inc shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on August 08, 2023. The new note on the price target was released on June 26, 2023, representing the official price target for FibroGen Inc stock.
The Average True Range (ATR) for FibroGen Inc is set at 0.07, with the Price to Sales ratio for FGEN stock in the period of the last 12 months amounting to 0.43.
FGEN Stock Performance Analysis:
FibroGen Inc [FGEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 69.39. With this latest performance, FGEN shares gained by 45.71% in over the last four-week period, additionally plugging by 104.50% over the last 6 months – not to mention a drop of -64.73% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for FGEN stock in for the last two-week period is set at 75.03, with the RSI for the last a single of trading hit 81.17, and the three-weeks RSI is set at 70.64 for FibroGen Inc [FGEN]. The present Moving Average for the last 50 days of trading for this stock 0.4992, while it was recorded at 0.5989 for the last single week of trading, and 0.6289 for the last 200 days.
Insight into FibroGen Inc Fundamentals:
FibroGen Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.16 and a Current Ratio set at 1.28.
FGEN Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for FGEN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for FibroGen Inc go to 49.32%.
FibroGen Inc [FGEN] Institutonal Ownership Details
The top three institutional holders of FGEN stocks are: PRIMECAP MANAGEMENT CO/CA/ with ownership of 13.66 million shares, which is approximately 13.6785%. ARMISTICE CAPITAL, LLC, holding 8.94 million shares of the stock with an approximate value of $$7.97 million in FGEN stocks shares; and ARMISTICE CAPITAL, LLC, currently with $$5.25 million in FGEN stock with ownership which is approximately 5.9458%.
